Imagen de Portada

Biomarkers of Parkinson's disease in perspective of early diagnosis and translation of neurotrophic therapies

Fuente: Wiley Open Access

Guardado en:

Detalles Bibliográficos
Autores principales:	Raimo K. Tuominen, Juho‐Matti Renko
Formato:	Artículo Open Access
Publicado:	Wiley 2024
Materias:	Basic & Clinical Pharmacology & Toxicology
Acceso en línea:	Acceder al recurso
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

A review on the new age methodologies for early detection of Alzheimer's and Parkinson's disease
por: Nabanita Ghosh, et al.
Publicado: (2024)

Effects of quercetin in preclinical models of Parkinson's disease: A systematic review
por: Camila de Oliveira Vian, et al.
Publicado: (2024)

Optimizing autophagy modulation for enhanced TRAIL‐mediated therapy: Unveiling the superiority of late‐stage inhibition over early‐stage inhibition to overcome therapy resistance in cancer
por: Kazi Mohammad Ali Zinnah, et al.
Publicado: (2024)

Therapeutic applicability of cannabidiol and other phytocannabinoids in epilepsy, multiple sclerosis and Parkinson's disease and in comorbidity with psychiatric disorders
por: Maria de Fátima dos Santos Sampaio, et al.
Publicado: (2024)

Regulation of mitochondrial dysfunction by estrogens and estrogen receptors in Alzheimer's disease: A focused review
por: Shokouh Arjmand, et al.
Publicado: (2024)

The effectiveness and safety of botulinum toxin injections for managing motor disorders of patients with Parkinson's disease: A meta‐analysis of randomized controlled trials
por: Fang Gao, et al.
Publicado: (2024)

Association Between Furosemide and Risk of Parkinson's Disease in a Nested Case–Control Study
por: Barkat Babar, et al.
Publicado: (2026)

Proton Pump Inhibitors and Biomarkers of Haemostasis in Postmenopausal Women: The Buffalo OsteoPerio Study
por: Ahmed I. Soliman, et al.
Publicado: (2025)

Gentiopicroside Attenuated Dopaminergic Neurodegeneration via Inhibiting Neuroinflammatory Responses and Ferroptosis in Experimental Models of Parkinson's Disease
por: Fangling Sun, et al.
Publicado: (2025)

Neurodegenerative disorders: Advances in neurobiology and new treatment perspectives
por: Sâmia Joca
Publicado: (2024)

The Incidence of Benzodiazepine and Benzodiazepine‐Related Drug Use in People With and Without Parkinson's Disease—A Nationwide Cohort Study
por: Veera Lonka, et al.
Publicado: (2025)

Ameliorative Role of β‐Caryophyllene on Antioxidant Biomarkers in a Paroxetine‐Induced Model of Male Sexual Dysfunction
por: Elijah Oluwatosin Olopade, et al.
Publicado: (2025)

An overview of major depression disorder: The endocannabinoid system as a potential target for therapy
por: Sergio Zarazúa‐Guzmán, et al.
Publicado: (2024)

Exposure to lidocaine in early life does not cause negative long‐term behavioural changes in mice
por: Sonja Buratovic, et al.
Publicado: (2024)

A study of the genotoxicity, fertility and early embryonic development toxicity of rotigotine behenate extended‐release microspheres
por: Xinyu Zhao, et al.
Publicado: (2024)

Safety evaluation of adenosine, lidocaine and magnesium (ALM) intranasal therapy toward human nasal epithelial cells in vitro
por: Jodie L. Morris, et al.
Publicado: (2024)

Dementia and neurodegenerative diseases: What is known and what is promising at the cellular and molecular level
por: Olesia F. Moroz, et al.
Publicado: (2024)

Exploring the role of oxidative stress and the effect of N‐acetylcysteine in thiopurine‐induced liver injury in inflammatory bowel disease: A randomized crossover pilot study
por: Dirk P. van Asseldonk, et al.
Publicado: (2024)

Methotrexate accumulation in target intestinal mucosa and white blood cells differs from non‐target red blood cells of patients with Crohn's disease
por: Maartje M. van de Meeberg, et al.
Publicado: (2024)

Matrix metalloproteinases are associated with severity of disease among COVID‐19 patients: A possible pharmacological target
por: Gisele Lopes Cavalcante, et al.
Publicado: (2024)

Drugs targeting APOE4 that regulate beta‐amyloid aggregation in the brain: Therapeutic potential for Alzheimer's disease
por: Joan Poblano, et al.
Publicado: (2024)

Transient receptor potential channels as an emerging target for the treatment of Alzheimer's disease: Unravelling the potential of pharmacological interventions
por: Nishit Joshi, et al.
Publicado: (2024)

The role of ATP‐binding cassette transporter G1 (ABCG1) in Alzheimer's disease: A review of the mechanisms
por: Mohsen Karbasi Yazdi, et al.
Publicado: (2024)

From Hospital to Home: Patient Experiences With Medication Counselling for Colorectal Cancer
por: K. Kvarnström, et al.
Publicado: (2025)

Poisonings With Opioids and Benzodiazepines in Denmark: A Retrospective Study From the Danish Poison Information Centre
por: Alba K. V. Sigfredsson, et al.
Publicado: (2025)

BCPT 2026 Policy for Experimental and Clinical Studies
por: Pernille Tveden‐Nyborg, et al.
Publicado: (2025)

Real‐World Complexity of Prescribing Cascades
por: J. T. H. Nielen, et al.
Publicado: (2025)

In Vitro Antitrypanosomal and Antibacterial Activity of Aqueous, Hydroethanolic and Ethanolic Extracts of Rumex obtusifolius L. Leaf and Root
por: Gabriela K. Borges, et al.
Publicado: (2026)

Methadone pharmacokinetics in opioid agonist treatment: Influencing factors and clinical implications
por: Fatemeh Chalabianloo, et al.
Publicado: (2024)

Electrochemical Point‐of‐Care Test for Assessing Serum Paracetamol Concentration: Comparison With Traditional Methods and Detection of Concomitant Drugs
por: Johanna K. Kujala, et al.
Publicado: (2025)

sGC stimulator (BAY 41‐8543) combined with PDE9 inhibitor (BAY 73‐6691) reduces renal fibrosis in 5/6 nephrectomized rats
por: Xin Chen, et al.
Publicado: (2024)

Promoting Resiliency to Stress in the Vascular Endothelium
por: Maria J. Jaramillo‐Torres, et al.
Publicado: (2025)

Four weeks SGLT2 inhibition improves beta cell function and glucose tolerance without affecting muscle free fatty acid or glucose uptake in subjects with type 2 diabetes
por: Jens Hohwü Voigt, et al.
Publicado: (2024)

Therapeutic benefit of melatonin in 5‐fluorouracil‐induced renal and hepatic injury
por: Razieh Mansoori, et al.
Publicado: (2024)

Issue Information
Publicado: (2024)

CYP3A4*22 and bleeding risk in ticagrelor users
por: Innocent G. Asiimwe, et al.
Publicado: (2024)

Limited sampling approach for model‐informed precision dosing of daptomycin to rapidly achieving the target area under the concentration‐time curve: A simulation study
por: Tomoyuki Yamada, et al.
Publicado: (2024)

Decreased blood pressure with acute administration of quercetin in L‐NAME‐induced hypertensive rats
por: Siluleko A. Mkhize, et al.
Publicado: (2024)

Pregnane X receptor activation induces liver enlargement and regeneration and simultaneously promotes the metabolic activity of CYP3A1/2 and CYP2C6/11 in rats
por: Guofang Bi, et al.
Publicado: (2024)

The alleviatory effects of koumine on MSU‐induced gouty arthritis via the TLR4/NF‐κB/NLRP3 pathway
por: Shi‐kang Lin, et al.
Publicado: (2024)